Skip to main content

RegMed XB

Regenerative Medicine Crossing Borders

Terms and Conditions

By agreeing to these terms you indicate you are employed by one of the RegMed XB signatory partners. As such you are bound by strict confidentiality as described in the consortium agreement.

This portal and all of its information and documents are confidential and/or proprietary information and is intended for RegMed XB consortium partners only. Any unauthorized use of the information contained herein (including, but not limited to, alteration, reproduction, communication, distribution or any other form of dissemination) is strictly prohibited. If you are not the employed by a RegMed XB consortium partner, please notify the RegMed XB office (This email address is being protected from spambots. You need JavaScript enabled to view it.) promptly and delete all obtained information/documents subsequently.

Please refer to the RegMed XB Phase 1 consortium agreement for the full Terms & Conditions

RegMed XB Consortium partners:

300MICRONS
Access2bone
Chemelot InSciTe
CytoSMART
Diabetesfonds Nederland
TU Eindhoven
Foundation RegMed XB
Fujifilm Manufacturing
Galapagos
Hartstichting
HCM-Medical
Innophysics

KU Leuven
Kuros
Leiden UMC
Leiden Regenerative Medicine Platform (LRMP)
Nierstichting
LifeTec Group
Maastricht University
Materiomics
Mimetas
Ncardia
Nestegg

NTrans
Osteo-Pharma
ReumaNederland
STENTiT
Stichting DON
Suprapolix
UMC Utrecht
Utrecht University
Veldlaser
Visualsonics
Xeltis
Other (event registration only)